Fund HoldingsLynx1 Capital Management LP

Total Portfolio Value
$279.23M
Total Bought
$124.15M
Total Sold
$18.23M
Net Transaction
+$105.91M
Filing Period:
Securities
SharesValue ($K)
Q4 2024
Q1 2025
Change
Q4 2024
Q1 2025
Weight (%)
Change
GH RESEARCH PLC(GHRS)4,858,9946,443,940+1,584,94634,01371,07725.45%+37,064
PROTAGONIST THERAPEUTICS INC0733,014+733,014035,44912.69%+35,449
CULLINAN THERAPEUTICS INC(CGEM)1,257,7953,215,722+1,957,92715,32024,3438.72%+9,023
IBIO INC862,279862,27902,1133,4661.24%+1,354
PRECISION BIOSCIENCES INC766,051766,05102,9193,6541.31%+735
DESIGN THERAPEUTICS INC065,954+65,95402550.09%+255
NEUPHORIA THERAPEUTICS INC45,80645,80601572640.09%+107
REPARE THERAPEUTICS INC79,1760-79,1761040-104
CENTESSA PHARMACEUTICALS PLC17,4000-17,4002910-291
MERUS N V1,580,8411,568,841-12,00066,47466,03323.65%-442
VOR BIOPHARMA INC(VOR)637,2180-637,2187070-707
CARIBOU BIOSCIENCES INC680,1890-680,1891,0820-1,082
PASSAGE BIO INC9,256,9539,256,95305,2503,2691.17%-1,981
UPSTREAM BIO INC240,042219,247-20,7953,9461,3420.48%-2,604
ALLAKOS INC3,628,1440-3,628,1444,3900-4,390
ALLOGENE THERAPEUTICS INC10,874,72311,057,009+182,28623,16316,1435.78%-7,020
KEROS THERAPEUTICS INC544,0010-544,0018,6120-8,612
TSCAN THERAPEUTICS INC5,357,3475,357,347016,2867,3932.65%-8,893
C4 THERAPEUTICS INC6,852,7447,098,133+245,38924,67011,3574.07%-13,313
STOKE THERAPEUTICS INC(STOK)5,187,1915,291,929+104,73857,21535,19112.60%-22,023
Page 1 of 1